28636-21-7; methyl ester; AC1L42EA;methyl
(2R,3S,4R)-4-[(2R,5R,7S,8R,9S)-2-[(2R,5S)-5-ethyl-5-[(2S,3R,5S)-5-[(2S,
3S,5R,6R)-6-hydroxy-6-(hydroxymethyl)-3,
5-dimethyloxan-2-yl]-3-methyloxolan-2-yl]oxolan-2-yl]-7-hydroxy-2,
8-dimethyl-1,10-dioxaspiro[4.5]decan-9-yl]-3-methoxy-2-methylpentanoate; AG-E-92105; CTK8G1168;Monensin; 

oxygen(-2) anion; molybdenum; AC1L55LW; hydrate;40957-85-5;molybdenum; oxygen(2-);oxygen(2-);hydrate; 

alpha-bromo-; sodium salt;2-bromopentanoate;Sodium 2-bromovalerate; 2-bromo-; Valeric acid;sodium; Sodium alpha-bromovalerate; 

FT-0688303;(2S,3S,4S,5R,6R)-6-[[(3S,4aR,6aR,6bS,8aS,12aS,14aR,14bR)-8a-carboxy-4,4,
6a,6b,11,11,14b-heptamethyl-1,2,3,4a,5,6,7,8,9,10,12,12a,14,
14a-tetradecahydropicen-3-yl]oxy]-3,5-dihydroxy-4-[(2S,3R,4S,5R)-3,4,
5-trihydroxyoxan-2-yl]oxyoxane-2-carboxylic acid; 195971-47-2; MolPort-020-005-783; 96990-18-0;Momordin Ic; X1188; Scoparianoside B; AKOS015897153; CHEMBL470172; AC1L427O; 

16-deethyl-16-methyl-; 30485-16-6; 16-Deethyl-16-methylmonensin;AC1MIYKU;4-[9-hydroxy-3-[5-[5-[6-hydroxy-6-(hydroxymethyl)-3,
5-dimethyloxan-2-yl]-3-methyloxolan-2-yl]-5-methyloxolan-2-yl]-3,
8-dimethyl-1,6-dioxaspiro[4.5]decan-7-yl]-3-methoxy-2-methylpentanoic
acid; Monensin; 

CTK5E1961; AC1Q1VPQ; monosodium salt;75761-64-7; 26-((4-bromophenyl)carbamate);4-[2-[5-[5-[6-[(4-bromophenyl)carbamoyloxymethyl]-6-hydroxy-3,
5-dimethyloxan-2-yl]-3-methyloxolan-2-yl]-5-ethyloxolan-2-yl]-7-hydroxy-
2,8-dimethyl-1,
10-dioxaspiro[4.5]decan-9-yl]-3-methoxy-2-methylpentanoate;sodium; Monensin; 

2-[5-Ethyltetrahydro-5-[tetrahydro-3-methyl-5-[tetrahydro-6-hydroxy-6-(hydroxymethyl)-3,5-dimethyl-2H-pyran-2-yl]-2-furyl]-2-furyl]-9-hydroxy-beta-methoxy-alpha,gamma,2,8-tetramethyl-1,6-dioxaspiro[4.5]decane-7-butyric acid;Monensin;